Surrozen
Pre-clinicalSurrozen is a biotechnology company, pioneering a new class of Wnt-based therapeutics.
Founded
2015
Focus
AntibodiesBiologics
About
Surrozen is a biotechnology company, pioneering a new class of Wnt-based therapeutics.
Funding History
3Total raised: $145M
IPO$75MUndisclosedAug 6, 2021
Series B$50MThe Column GroupJun 15, 2018
Series A$20MThe Column GroupJun 15, 2016
Company Info
TypePrivate
Founded2015
LocationSouth San Francisco, United States
StagePre-clinical
Contact
Sectors
SIMILAR COMPANIES
BASi Research Products
Pre-clinical · West Lafayette
Bay BioSciences
Pre-clinical · San Francisco
EydisBio
Pre-clinical · Cambridge
3Spine
Pre-clinical · Memphis
Belcher Pharmaceuticals
Pre-clinical · Miami
Is this your company?
Claim your profile to update information, add pipeline data, and connect with investors.
Claim profile